Agent for treating, preventing or improving psychiatric and nervous system disorders or symptoms
WO2021054351A1
Membrane permeation enhancer and method for enhancing membrane permeation
WO2021049564A1
Photobase generator, compound, photoreactive composition, and reaction product
WO2021049563A1
Photobase generator, compound, photoreactive composition, and reaction product
WO2021039923A1
Abnormal state estimation device, sole state estimation device, system, and program
WO2021039800A1
Method for preparing enantiomer of sulfoxide compound, and system for preparing enantiomer
WO2021075147A1
Brap2 action enhancer
WO2021029238A1
Agent for preventing or treating th17 cell-induced disease and screening method for agents for preventing or treating th17 cell-induced disease
WO2021006353A1
Method for amplifying nucleic acid using solid-phase carrier
WO2021006248A1
Noble gas hydride, fuel, and method for producing noble gas hydride
WO2020250736A1
Active energy ray-curable composition
WO2020175711A1
Compound, carbon dioxide absorption/release agent, method for collecting carbon dioxide, and apparatus for collecting carbon dioxide
WO2020138228A1
Jasmonic acid endogeny promoting agent, and method for promoting jasmonic acid endogeny
WO2020045458A1
Curable composition, cured product, and method for producing cured product
WO2020022514A1
Molded article manufacturing method, imprint-electronic writing collective molding resist, replica mold manufacturing method, device manufacturing method, and imprint material
WO2020013271A1
Screening method for anti-obesity substance, and kit for screening for anti-obesity substance
WO2019225600A1
Method for evaluating hydrogel
WO2019216422A1
REGULATORY-T-CELL-INCREASING AGENT, CLOSTRIDIUM CLUSTER XIVa GROWTH PROMOTER, AND COMPOSITION FOR PREVENTION, TREATMENT, OR IMPROVEMENT OF INFLAMMATORY OR ALLERGIC DISEASE OR SYMPTOM
WO2019216322A1
Curable composition, compound, base conversion proliferator, and cured article
